article thumbnail

The potential of AI in pharma R&D

Pharmaceutical Technology

Developing a new drug is a monumental achievement — the reward of years of research and innovation. Successful innovation requires enormous effort from countless project teams that build on the medical, scientific and technological research and development of generations before them. How is AI used in the pharmaceutical industry?

article thumbnail

EFPIA states AI rules must “enable not hinder” pharma R&D

Drug Discovery World

Significantly for drug discovery, ‘scientific research and development’ is excluded from the scope of the Act, though this will be defined further in future guidance. The AI Act, which bans certain AI applications that it feels threaten citizens’ rights, was approved in the European Parliament in March 2024.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Transforming pharma R&D with a scientist-centric approach to AI & automation

pharmaphorum

Markus Gershater co-founded Synthace after working as a research associate in Synthetic Biology at University College London where he developed novel biosynthesis methods using pathway engineering.

article thumbnail

Despite COVID-19, pharma R&D funding at all-time high: IQVIA

Outsourcing Pharma

According to the clinical research solutions firm, disruptions due to the pandemic did not stop the industry from fueling R&D at unprecedented levels.

article thumbnail

Why VCs fell in love with pharma R&D in 2021

pharmaphorum

For many years, those inside the pharma industry have been telling the same old story about innovation: pharma is big, slow, and risk averse. That culture clash makes it hard to innovate the world of pharma at scale and with any rapidity. Start-ups move fast and break things.

article thumbnail

Quantum Computing: Boehringer Ingelheim and Google Partner for Pharma R&D

The Pharma Data

.–( BUSINESS WIRE )– Boehringer Ingelheim announced today a collaborative agreement with Google Quantum AI (Google), focusing on researching and implementing cutting-edge use cases for quantum computing in pharmaceutical research and development (R&D), specifically including molecular dynamics simulations.

article thumbnail

#news #biotech Chutes & Ladders—Arena Pharma R&D chief Cabell leaves post after 6 months

BioTech 365

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Chutes & Ladders—Arena Pharma R&D chief Cabell leaves post after 6 months.Chutes & Ladders—Arena Pharma R&D chief Cabell leaves post after 6 months kblankenship Thu, 12/03/2020 – … Continue reading (..)